ctrl K

Watchlist Price Alert

Impel Pharmaceuticals Inc... (IMPL)

NASDAQ: IMPL · Real-Time Price · USD

0.04

-0.01 (-27.27%)

At close: Dec 20, 2023, 8:58 PM

Impel Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	60.65M	88.21M	7.09M	37M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.75M	187K	187K	-2.74M
Receivables	7.44M	1.35M	n/a	n/a
Inventory	8.43M	2.82M	-229K	-201K
Other Current Assets	3.28M	2.19M	1.08M	2.52M
Total Current Assets	79.81M	94.58M	8.17M	39.52M
Property-Plant & Equipment	7M	3.15M	3.7M	2.74M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.74M	3.34M	3.89M	2.74M
Total Assets	88.55M	97.91M	12.06M	42.27M
Account Payables	6.09M	6.37M	4.31M	2.73M
Deferred Revenue	n/a	n/a	3.17M	n/a
Short-Term Debt	1.54M	n/a	417K	n/a
Other Current Liabilities	14.53M	9.59M	2.62M	5.6M
Total Current Liabilities	22.16M	15.95M	10.53M	8.32M
Long-Term Debt	49.65M	29.45M	7.99M	n/a
Other Long-Term Liabilities	60.9M	n/a	127.04M	n/a
Total Long-Term Liabilities	110.54M	29.45M	135.03M	125.65M
Total Liabilities	132.71M	45.4M	145.56M	133.97M
Total Debt	51.19M	29.45M	8.41M	n/a
Common Stock	24K	23K	n/a	6K
Retained Earnings	-321.11M	-214.8M	-138.26M	-92.46M
Comprehensive Income	n/a	-97.91M	n/a	-125.65M
Shareholders Equity	-44.16M	52.51M	-133.5M	-91.7M
Total Investments	n/a	n/a	n/a	n/a